Transitioning from Aflibercept to Biosimilar Ranibizumab in Neovascular AMD (The TRANSFORM Trial): A Multicenter Observational Study.

Debdulal ChakrabortySubhendu BoralTushar Kanti SinhaArnab DasAngshuman MukherjeeSaptorshi MajumdarRanabir BhattacharyaRitobroto Maitra

Published in: Clinical ophthalmology (Auckland, N.Z.) (2024)

The switch from IVI AFL to IVI B-RBZ in patients with nAMD demonstrated efficacy in maintaining the VA and macular anatomy, with some challenges in fluid management.

Keyphrases

age related macular degeneration
phase iii
study protocol
clinical trial
phase ii
cross sectional
open label
diabetic retinopathy